Kidney News

Kidney News

Features

Decreased exercise capacity and cardiovascular risk are integral features of chronic kidney disease (CKD), with a debilitating impact on quality of life and survival.

Practice Pointers

Kidney News Editorial Board member Edgar Lerma, MD, FASN, interviewed George Bakris, MD, FASN, about clinicians’ experience with the 2017 American College of Cardiology/American Heart Association (ACC/AHA) Hypertension Guidelines (1).

Findings

Sodium-glucose cotransporter-2 (SGLT2) inhibitors lower the risk of dialysis and other clinically important kidney outcomes in patients with type 2 diabetes, concludes a systematic review and meta-analysis in The Lancet Diabetes & Endocrinology.

Industry Spotlight

Two companies recently announced clinical trials for promising drug candidates for kidney diseases.

April 2017 Issue

In November 2017, KDIGO hosted a Controversies Conference in Singapore on glomerular diseases.

All Issues

Read past issues of
ASN Kidney News.

Established in 2009, ASN Kidney News has kept the kidney community informed of the latest clinical, scientific, and policy issues affecting kidney health professionals and patients with kidney disease.

Video Library

ASN Executive Director Tod Ibrahim discusses a variety of nephrology related topics.

ASN Executive Director Tod Ibrahim discusses a variety of nephrology related topics.

ASN Executive Director Tod Ibrahim discusses a variety of nephrology related topics. The American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.